Denmark
CLINIGMA specializes in involving patients in the medical product development process as partners and experts in their own experiences. Recognizing the importance of patient experience data, the company aligns with recent guidance from the US Food and Drug Administration (FDA).
The startup, previously named Clinical Survey Outcomes, boasts qualitative researchers adept at capturing and synthesizing patient input to inform the development process for pharmaceutical companies.
CLINIGMA conducts in-depth interviews with patients participating in clinical trials, tailoring questionnaires, and providing qualitative research in real-world settings. With access to strong patient, physician, and key opinion leader panels, the company aims to enhance regulatory decision-making and support clients in demonstrating the relationship between patient experiences in clinical trials and real life.
As the company's vision is to be the structured voice of trial patients, CLINIGMA strives to bring clarity and value to the pharmaceutical companies it collaborates with.
